26U vs PPGN: Side-by-Side Comparison
Compare 26U (26U) and PolyPeptide Group AG (PPGN) side by side: market cap EUR 127.86M vs CHF 1.59B. Financials, growth and model signals on Bullrun.
| Metric | 26U | PPGN |
|---|---|---|
| Company | 26U | PolyPeptide Group AG |
| Country / Exchange | Switzerland · F | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 127.86M | CHF 1.59B |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 10.80M | CHF 391.87M |
| Revenue growth YoY | +56.6% | +15.7% |
| Net income | EUR -1.42M | CHF -21.17M |
| Gross margin | 26.3% | 17.0% |
| Diluted EPS | -0.28 | -0.64 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.